HOME >> BIOLOGY >> NEWS
Genomatix technology facilitates de novo identification of new renal disease associated genes

Previously unknown molecules and regulatory pathways in human glomerular diseases have been identified by a joint effort of the Medizinische Poliklinik, Munich, the University of Bristols Childrens Renal Unit, the German Cancer Research Center, sanofi-aventis, and Genomatix Software GmbH.

In a joint publication in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) above groups show how new bioinformatics approaches allow rapid characterization of shared promoter structures which can be used to find novel interacting molecules. Here, these principles are applied to a set of genes linked to the unique functional unit of the glomerular slit diaphragm. An evolutionarily conserved promoter model was generated. Genome-wide scans using this promoter model effectively predicted a previously unrecognized slit diaphragm molecule which was then experimentally verified.

This publication shows a straightforward approach how comparative promoter analysis can identify regulatory pathways at work in tissue homeostasis and disease processes.


'"/>

Contact: Klaus May
may@genomatix.de
49-89-599-7660
Genomatix Software GmbH
3-Apr-2006


Page: 1

Related biology news :

1. Genomatix expands operations in North America
2. Application of Genomatix in silico methods reveals novel cancer associated genes
3. Genomatix and Molecular Connections form strategic partnership
4. Genomatix wins BioChance grant worth $1.6 million
5. Genomatix appoints distributor for the growing Chinese market
6. MatBase -- A new transcription factor knowledge base released by Genomatix
7. The Center of Nutrigenomics of the TU Munich licences Genomatix Microarray Analysis Pipeline
8. Bayer HealthCare licenses Genomatix for microarray analysis
9. Genomatix partners with Research Instruments Pte Ltd for Singapore, Malaysia and Thailand markets
10. German Microarray Excellence Center integrates Genomatix Chip Analysis Pipeline
11. Genomatix improves its coverage of Affymetrix new exon arrays

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 21, 2020 , ... ... services specializing in background and medical screening, announces the launch of a ... keeping their workforce safe. The new service is provided by ClearStar’s Medical ...
(Date:5/21/2020)... ... May 20, 2020 , ... Law Enforcement has always been a highly stressful ... The positions of these men and women put them constantly in harm’s way both ... precisely. Officers have always had to face very high daily stress. Now, COVID-19 introduces ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... Life Science Manufacturers accurately and easily project contracted liabilities with payers, providers ... models by projecting discounts/rebates to Commercial and Government entities, Copay and Patient ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... ... May 29, 2020 , ... The Conference Forum ... newsletter solely dedicated to the unique role of the Chief Medical Officer in ... the responsibilities, problem-solving, best practices and career development of CMOs and Heads of ...
(Date:5/28/2020)... ... 2020 , ... The Security Industry Association (SIA) and SecureIDNews ... the Women in Biometrics Awards – a globally recognized program co-founded by ... and the SIA Women in Security Forum . The honorees will be recognized ...
(Date:5/21/2020)... ... 2020 , ... Threats to intellectual property, political pressure to ... conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a ... pandemic commercially weaker, dealing with delays in new product launches and with fewer ...
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast of ... strategy and M&A advisory firm. , This is an important step for Eaton Square ... healthcare innovators with capital and investors. , Popper and Company, founded in 2003 by ...
Breaking Biology Technology:
Cached News: